Aristotle Atlantic Partners, LLC Vertex Pharmaceuticals Inc Transaction History

Aristotle Atlantic Partners, LLC

$3.19 Billion
Q3 2024

A detailed history of Aristotle Atlantic Partners, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Aristotle Atlantic Partners, LLC holds 54,094 shares of VRTX stock, worth $22.2 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares

54,094

Previous 52,586 2.87%

Holding current value

$22.2 Million

Previous $24.6 Million 2.07%

% of portfolio

0.79%

Previous 0.8%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $693,680 - $762,716	1,508 Added 2.87%	54,094 $25.2 Million
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $2.41 Million - $2.98 Million	-6,136 Reduced 10.45%	52,586 $24.6 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $12.7 Million - $13.9 Million	31,135 Added 112.86%	58,722 $24.5 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $6.28 Million - $7.52 Million	18,313 Added 197.47%	27,587 $11.2 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $124,450 - $133,385	-368 Reduced 3.82%	9,274 $3.22 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $2.48 Million - $2.78 Million	7,900 Added 453.5%	9,642 $3.39 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $3,681 - $4,200	13 Added 0.75%	1,742 $548,000
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $2,286 - $2,571	-8 Reduced 0.46%	1,729 $499,000
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $70,648 - $78,826	258 Added 17.44%	1,737 $503,000
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $131,107 - $163,242	558 Added 60.59%	1,479 $417,000
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $203,927 - $240,353	921 New	921 $240,000
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $11.2 Million - $12.5 Million	-61,548 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $11.5 Million - $13.6 Million	61,548 New	61,548 $12.4 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Atlantic Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Atlantic Partners, LLC with notifications on news.

Account

Aristotle Atlantic Partners, LLC Vertex Pharmaceuticals Inc Transaction History